These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4432862)

  • 1. Suppressive therapy of nontoxic goiter.
    Shimaoka K; Sokal JE
    Am J Med; 1974 Oct; 57(4):576-83. PubMed ID: 4432862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative treatment of goiter from a surgical viewpoint].
    Keminger K
    Wien Med Wochenschr; 1971 Feb; 121(9):158-60. PubMed ID: 5555431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of recurrence by means of a thyroxine-triiodothyronine combination following strumectomy].
    Riccabona G; Scholz K; Bauer H
    Bruns Beitr Klin Chir (1971); 1971 Jun; 218(7):611-6. PubMed ID: 5095099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Asymptomatic struma. Nuclear-medical diagnosis and therapy].
    Hör G; Frey KW
    Med Klin; 1973 Sep; 68(36):1164-70. PubMed ID: 4125910
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional autonomy in multinodular goiter.
    Miller JM; Block MA
    JAMA; 1970 Oct; 214(3):535-9. PubMed ID: 4195884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of nontoxic goiter with synthetic thyroid hormones].
    Horster FA; Wildmeister W
    Dtsch Med Wochenschr; 1973 Mar; 98(11):525-8. PubMed ID: 4694993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Single weekly doses of 1 mg 1-thyroxine for the treatment of mild goiter and for the prevention of recurrence after goiter surgery].
    Bauhofer G; Hugl H; Zechmann W; Riccabona G
    Acta Med Austriaca; 1976; 3(2):54-8. PubMed ID: 826103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse nontoxic and multinodular goiter.
    Nakhjavani M; Gharib H
    Curr Ther Endocrinol Metab; 1997; 6():109-12. PubMed ID: 9174716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of non-toxic goitre: results of combined treatment with 100 micrograms L-thyroxine and 10 microgram L-triiodothyronine (author's transl)].
    Pickardt CR; Gärtner R; Habermann J; Horn K; Scriba PC; Horster FA; Wagner H; Hengst K
    Dtsch Med Wochenschr; 1981 May; 106(18):579-83. PubMed ID: 6783381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications and results of endemic goiter drug therapy with synthetic thyroid hormones].
    Horster FA; Wildmeister W
    Acta Endocrinol Suppl (Copenh); 1973 Oct; 179():89-90. PubMed ID: 4523787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnosis and therapy of nodular goiter].
    dos Anjos MN; Lima SC
    Hospital (Rio J); 1970 May; 77(5):1713-8. PubMed ID: 5311606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic suppression of TSH secretion in bland struma, recurring struma and recurrence prevention following struma resection].
    Pickardt CR; Erhardt F; Horn K; Lehnert P; Schriba PC
    Verh Dtsch Ges Inn Med; 1974; 80():1352-5. PubMed ID: 4454419
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the problem of recurrence in operated juvenile strumas].
    Stoltze D; Gottschalk E
    Z Arztl Fortbild (Jena); 1968 Nov; 62(22):1217-21. PubMed ID: 5731184
    [No Abstract]   [Full Text] [Related]  

  • 14. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Goiter. Diagnosis and therapy in practice].
    Horster FA
    ZFA (Stuttgart); 1979 Jan; 55(3):127-11. PubMed ID: 105484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problem of recurrent struma and its prevention].
    Becker T; Markgraf E; Zinner P
    Zentralbl Chir; 1971 Sep; 96(38):1320-6. PubMed ID: 5144496
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of bland goiter using a combination of L-thyroxine and L-triiodothyronine: control of hormone iodine, Hamolsky-value and radioiodine uptake].
    Horster FA; Klein E; Bock D; Wildmeister W; Bauer A
    Verh Dtsch Ges Inn Med; 1971; 77():663-6. PubMed ID: 5155923
    [No Abstract]   [Full Text] [Related]  

  • 18. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?
    Hegedüs L; Nygaard B; Hansen JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):756-60. PubMed ID: 10022449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of euthyreotic struma].
    Emrich D
    Dtsch Med Wochenschr; 1980 Apr; 105(16):570-4. PubMed ID: 6988195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.